. The impact will be particularly felt in the pharmaceutical industry, the justification for the draft regulation states, according to the authorities, the budget effect will be minus 290 million lei as a result of this legislative change.
According to the rationale, the expected change was taken into account in order to bring local VAT legislation into line with the Community acquis, in the light of the decision of the Court of Justice of the European Union (CJEU) in Case C -717/19 – Boehringer Ingelheim in the pharmaceutical sector. According to current legislation, price discounts are provided in the distribution chain, not provided for in the case of discounts that are not provided directly to the customer.
Read the rest of the article on the PwC Romania blog
The article is signed by Ruxandra Tarlescu, Partner, and Adina Vizoli, Director
Article supported by PwC Romania
Source: Hot News
Lori Barajas is an accomplished journalist, known for her insightful and thought-provoking writing on economy. She currently works as a writer at 247 news reel. With a passion for understanding the economy, Lori’s writing delves deep into the financial issues that matter most, providing readers with a unique perspective on current events.